RealFeedApp ExoCordOA project runs for five years
The ExoCordOA consortium unites ten organizations, including Lonza and Utrecht University, to develop therapies based on extracellular vesicles derived from umbilical cord blood.
- Field
- ageing and longevity
- What they did
- Exogenus Therapeutics is coordinating a consortium to develop secretome therapy enriched with extracellular vesicles, focusing initially on treating osteoarthritis.
- Why it matters
- The program aims to accelerate the clinical validation of candidate EXO-101 by overcoming current scientific, manufacturing, and regulatory challenges that hinder its translation into clinical practice.
#secretome#extracellular vesicles#exogenus#osteoarthritis#horizon europe
